Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clevudine in HBeAg Negative Chronic Hepatitis B
NCT00313274Phase 3Terminated
- Sponsor
- Bukwang Pharmaceutical
- Start
- Jul 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clevudine in Chronic Hepatitis B (CHB), sponsored by Bukwang Pharmaceutical. Started Jul 2003; status: terminated.
02
Drugs
clevudine
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00313274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00313274.